IP Library Granted Patent US 7,018,811
Granted Patent B2
US 7,018,811 · App. 09/989,726 · Granted Mar 28, 2006

Nucleic acids encoding PRO189 polypeptides

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,018,811
App. No.
09/989,726
Granted
Mar 28, 2006
Kind
B2
Abstract

The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

Claims (20)

1. An isolated nucleic acid comprising:

(a) a nucleic acid sequence encoding the polypeptide of SEQ ID NO: 326;

(b) a nucleic acid sequence encoding the polypeptide of SEQ ID NO: 326, lacking its associated signal peptide;

(c) the nucleic acid sequence of SED ID NO: 325;

(d) the full-length coding sequence of the cDNA deposited under ATCC accession number 203129;

wherein, said nucleic acid is amplified in colon tumors.

2. The isolated nucleic acid of claim 1 comprising the nucleic acid sequence of SEQ ID NO: 325.

3. The isolated nucleic acid of claim 1 comprising the full-length coding sequence of the nucleic acid sequence of SEQ ID NO: 325.

4. The isolated nucleic acid of claim 1 comprising the full-length coding sequence of the cDNA deposited under ATCC accession number 203129.

5. A vector comprising the nucleic acid of claim 1 .

6. The vector of claim 5 , wherein said nucleic acid is operably linked to control sequences recognized by a host cell transformed with the vector.

7. A host cell comprising the vector of claim 5 .

8. The host cell of claim 7 , wherein said cell is a CHO cell, an E. coli or a yeast cell.

9. An isolated nucleic acid molecule consisting of at least a 20 nucleotide fragment of the nucleic acid sequence of SEQ ID NO: 325 or a complement thereof that specifically hybridizes under stringent conditions to:

(a) the nucleic acid sequence of SEQ ID NO: 325 or a complement thereof; or

(b) the full-length coding sequence of the cDNA deposited under ATCC accession number 203129 or a complement thereof;

wherein, said stringent conditions use 50% formamide, 5× SSC, 50 mM sodium phosphate (pH 6.8), 0.1% sodium pyrophosphate, 5× Denhardt's solution, sonicated salmon sperm DNA (50 μg/ml), 0.1% SDS, and 10% dextran sulfate at 42° C., and washes at 42° C. in 0.2× SSC, at 55° C. in 50% formamide followed by a high-stringency wash at 55° C. in 0.1× SSC, EDTA; and wherein said isolated nucleic acid molecule is suitable for use as a PCR primer or probe.

10. The isolated nucleic acid molecule of claim 9 that is at least 25 nucleotides or greater in length.

11. The isolated nucleic acid molecule of claim 9 that is at least 30 nucleotides or greater in length.

12. The isolated nucleic acid molecule of claim 9 that is at least 35 nucleotides or greater in length.